微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 19.74% | 10.9% | 42.53% | 2/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 13.85% | 14.27% | 86.16% | 2/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 7.44% | 42.8% | -60.28% | 2/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 18.73% | 8.83% | 5.22% | 4/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 17.8% | 12.52% | 46.86% | 4/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 12.12% | 18.48% | 132.63% | 3/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 5.21% | 21.45% | -69.73% | 4/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 17.21% | -19.84% | 8.79% | 13/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 15.82% | -28.03% | 54.64% | 14/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 10.23% | -60.95% | 138.46% | 12/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 4.29% | -57.48% | -80.02% | 11/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 21.47% | -54.66% | -2.32% | 11/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 21.98% | -39.05% | -16.11% | 4/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 26.2% | 2% | 159.66% | 1/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 10.09% | -27.88% | -78.69% | 3/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 47.35% | -4.69% | 31.31% | 3/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 36.06% | 2% | 157.76% | 3/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-03-31 | 13.99% | 2% | -71.84% | 1/51 | -0.22% | 华大基因 | 48.52% | 行业排名> |
| 2019-12-31 | 49.68% | 48.34% | 48.34% | 5/51 | 65.31% | 华大基因 | 31.24% | 行业排名> |
| 2018-12-31 | 33.49% | 1135.79% | 1135.79% | 4/51 | -0.6% | 阳光诺和 | 13.99% | 行业排名> |
| 2017-12-31 | 2.71% | 2% | 2% | 33/51 | 1.73% | 南华生物 | 2848.07% | 行业排名> |